Stay updated on HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.

Latest updates to the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Added a government funding notice and operating status guidance, plus a pointer to cc.nih.gov; - Bumped version from v3.1.0 to v3.2.0.SummaryDifference2%
- Check16 days agoChange DetectedUpdated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content scope shift and a new version release.SummaryDifference0.2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations in South Korea and Taiwan, as well as new MedlinePlus related topics on drug safety and chronic diseases. Notably, previous entries related to hepatitis A and certain genetic diseases have been removed.SummaryDifference4%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.